DrugPatentWatch Database Preview
Details for Patent: 6,780,877
Which drugs does patent 6,780,877 protect, and when does it expire?
This patent has thirty-three patent family members in fifteen countries.
Summary for Patent: 6,780,877
Title: | Acid addition salt of optically active piperidine compound and process for preparing the same |
Abstract: | The present invention is to provide a benzenesulfonic acid salt and a benzoic acid salt of (S)-4-[4-[(4-chlorophenyl)(2-pyridyl)methoxy]piperidino]butanoic acid represented by the formula (I): ##STR1## wherein * represents an asymmetric carbon, which are excellent in antihistaminic activity and anti-allergic activity, and a process for producing the same. |
Inventor(s): | Kita; Jun-ichiro (Ube, JP), Fujiwara; Hiroshi (Ube, JP), Takamura; Shinji (Ube, JP) |
Assignee: | Ube Industries, Ltd. (Ube, JP) Tanabe Seiyaku Co., Ltd. (Osaka, JP) |
Application Number: | 09/949,809 |
Patent Claim Types: see list of patent claims | Compound; Process; Composition; |
Drugs Protected by US Patent 6,780,877
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Patent Submitted |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bausch And Lomb Inc | BEPREVE | bepotastine besilate | SOLUTION/DROPS;OPHTHALMIC | 022288-001 | Sep 8, 2009 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | Y | Y | ➤ Try a Free Trial | |||
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Patent Submitted |
Foreign Priority and PCT Information for Patent: 6,780,877
Non-Orange Book US Patents Family Members for Patent 6,780,877
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
Patent No. | Title | Estimated Patent Expiration |
---|---|---|
6,307,052 | Acid-addition salts of optically active piperidine compound and process for producing the same | ➤ Try a Free Trial |
7,282,589 | Acid addition salt of optically active piperidine compound and process for preparing the same | ➤ Try a Free Trial |
Patent No. | Title | Estimated Patent Expiration |
International Patents Family Members for US Patent 6,780,877
Country | Document Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 217872 | ➤ Try a Free Trial | |||
Australia | 7890698 | ➤ Try a Free Trial | |||
Canada | 2275987 | ➤ Try a Free Trial | |||
China | 1098262 | ➤ Try a Free Trial | |||
Country | Document Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |